Trials / Suspended
SuspendedNCT03439358
Magnesium for Shivering in Epidural Lidocaine Deliveries
Intravenous Magnesium Sulfate for the Prevention of Intraoperative Shivering in Parturients Undergoing Cesarean Delivery Under Lidocaine Top-up Via a Pre-existing Epidural Catheter Inserted for Labor Analgesia - A Randomized Double-blind, Placebo-controlled Trial
- Status
- Suspended
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 90 (estimated)
- Sponsor
- University of British Columbia · Academic / Other
- Sex
- Female
- Age
- 19 Years
- Healthy volunteers
- Accepted
Summary
Magnesium has been shown to decrease the shivering experienced from neuraxial anesthesia. This study aims to investigate whether magnesium decreases the shivering experienced in parturients undergoing labor epidural anesthesia for Cesarean delivery.
Detailed description
Women who have epidurals in place and go on to require a Cesarean delivery typically have their epidurals 'topped-up' with a fast onset local anesthetic to ensure the lower body is fully numb for surgery. This is called an epidural 'top-up'. However, a side effect of epidural top-ups is shivering, which is uncomfortable for the mother and interferes with patient monitoring. Magnesium administration has been shown to decrease shivering in the non-pregnant population. Therefore, in this study the investigators aim to determine if magnesium given prior to an epidural top-up decreases the incidence and severity of shivering in the pregnant population.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Magnesium Sulfate | Bolus infusion: 100mL normal saline with 4g MgSO4 over 30 minutes Maintenance infusion: 25mL normal saline per hour with 1g MgSO4 |
| OTHER | Normal Saline | Bolus infusion: 100mL normal saline over 30 minutes Maintenance infusion: 25mL normal saline per hour |
Timeline
- Start date
- 2018-06-11
- Primary completion
- 2021-09-01
- Completion
- 2021-09-01
- First posted
- 2018-02-20
- Last updated
- 2021-02-26
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT03439358. Inclusion in this directory is not an endorsement.